NCMHCE - National Clinical Mental Health Counseling Examination National Clinical Mental Health Counseling Examination Psychopharmacology and Co-occurring Disorders 1 — Questions and Answers
Question 1: A client with co-occurring major depressive disorder and opioid use disorder is stabilized on buprenorphine/naloxone (Suboxone) and asks whether they should also be taking an antidepressant. What is the MOST appropriate counselor response?
- Advise the client to discontinue buprenorphine before starting any antidepressant
- Encourage the client to discuss this with their prescribing physician, as integrated pharmacological treatment may benefit both conditions (Correct answer)
- Explain that antidepressants are contraindicated for clients on medication-assisted treatment
- Recommend the client wait at least six months of sobriety before considering antidepressants
Correct answer: Encourage the client to discuss this with their prescribing physician, as integrated pharmacological treatment may benefit both conditions
The counselor's role is to support integrated care while respecting scope of practice. Referring the client to their prescriber for medication decisions is appropriate, as evidence supports treating co-occurring depression and opioid use disorder simultaneously within a coordinated care model.
Question 2: A counselor observes that a client taking a second-generation (atypical) antipsychotic has gained 25 pounds over three months and now reports increased thirst and frequent urination. What is the MOST appropriate counselor action?
- Advise the client to discontinue the antipsychotic immediately to prevent further weight gain
- Recommend dietary changes and exercise without involving the prescribing physician
- Refer the client to their prescribing physician to evaluate for metabolic syndrome (Correct answer)
- Reassure the client that these symptoms are expected and not medically significant
Correct answer: Refer the client to their prescribing physician to evaluate for metabolic syndrome
Second-generation antipsychotics carry a well-documented risk for metabolic syndrome, including weight gain, hyperglycemia, and dyslipidemia. Increased thirst and urination may indicate new-onset diabetes. The counselor should promptly refer to the prescriber for medical evaluation rather than minimizing or independently managing these symptoms.
Question 3: A client with co-occurring generalized anxiety disorder and alcohol use disorder has been abstinent for 30 days. Their psychiatrist recommends buspirone for anxiety management. Why is buspirone PARTICULARLY well-suited for this client compared to benzodiazepines?
- Buspirone produces strong sedation that reduces alcohol cravings
- Buspirone is non-habit-forming and has no cross-tolerance with alcohol (Correct answer)
- Buspirone is the only FDA-approved anxiolytic for clients with substance use disorders
- Buspirone provides immediate relief of acute anxiety symptoms
Correct answer: Buspirone is non-habit-forming and has no cross-tolerance with alcohol
Buspirone is an azapirone anxiolytic that carries no dependence risk and has no cross-tolerance with alcohol or benzodiazepines, making it significantly safer for clients with alcohol use disorder. Unlike benzodiazepines, it does not potentiate alcohol's CNS depressant effects and takes several weeks to reach full efficacy.
Question 4: A client diagnosed with schizophrenia and cannabis use disorder insists that smoking cannabis helps control their psychotic symptoms better than their prescribed antipsychotic. How should the counselor BEST respond?
- Support the client's self-medication strategy, as subjective symptom relief is a valid treatment goal
- Acknowledge the client's perception while providing psychoeducation that THC can exacerbate psychotic symptoms and reduce antipsychotic effectiveness (Correct answer)
- Immediately contact the prescriber to increase the antipsychotic dosage without discussing it with the client first
- Agree that cannabis is less harmful than psychiatric medications and should be considered a harm reduction strategy
Correct answer: Acknowledge the client's perception while providing psychoeducation that THC can exacerbate psychotic symptoms and reduce antipsychotic effectiveness
Research consistently shows that THC in cannabis can worsen psychotic symptoms, increase relapse risk, and reduce antipsychotic efficacy in clients with schizophrenia spectrum disorders. The counselor should validate the client's experience empathically while delivering accurate psychoeducation to support informed treatment decisions.
Question 5: A client with co-occurring ADHD and stimulant use disorder asks about medication options for managing their ADHD symptoms. Which statement BEST reflects current clinical guidance for this population?
- Stimulant medications are strictly contraindicated for anyone with any history of substance use disorder
- Non-stimulant options such as atomoxetine may be preferred, and if stimulants are used, long-acting formulations with careful monitoring are recommended (Correct answer)
- The client must maintain at least five years of abstinence before ADHD treatment can be considered
- ADHD and stimulant use disorder rarely co-occur, suggesting the ADHD diagnosis should be reconsidered
Correct answer: Non-stimulant options such as atomoxetine may be preferred, and if stimulants are used, long-acting formulations with careful monitoring are recommended
Clients with co-occurring ADHD and stimulant use disorder can receive ADHD treatment, but clinicians often prefer non-stimulant medications like atomoxetine or bupropion to reduce misuse risk. If stimulants are prescribed, extended-release formulations are favored due to lower abuse potential and diversion risk, combined with close monitoring.
Question 6: A client taking a monoamine oxidase inhibitor (MAOI) for treatment-resistant depression mentions they enjoy drinking red wine with dinner several nights a week. What is the MOST critical safety concern the counselor should address?
- Red wine will reduce the therapeutic effectiveness of the MAOI over time
- Tyramine in red wine can cause a potentially fatal hypertensive crisis when combined with MAOIs (Correct answer)
- The tannins in red wine elevate MAOI blood serum levels to toxic concentrations
- MAOIs cause alcohol intolerance, so the client will feel physically ill after drinking
Correct answer: Tyramine in red wine can cause a potentially fatal hypertensive crisis when combined with MAOIs
MAOIs inhibit the enzyme that breaks down tyramine, an amino acid found in aged and fermented foods and beverages including red wine. Tyramine accumulation can trigger a sudden, severe hypertensive crisis — a life-threatening emergency. Clients on MAOIs require strict dietary education about tyramine-containing foods and beverages.
NCMHCE - National Clinical Mental Health Counseling Examination National Clinical Mental Health Counseling Examination Psychopharmacology and Co-occurring Disorders 1
A client with co-occurring major depressive disorder and opioid use disorder is stabilized on buprenorphine/naloxone (Suboxone) and asks whether they should also be taking an antidepressant.
What is the MOST appropriate counselor response?